MedPath

Use of a Mesh to Prevent Parastomal Hernia

Not Applicable
Completed
Conditions
Parastomal Hernia
Interventions
Device: Mesh (Ultrapro ®)
Procedure: Conventional sigmoid end colostomy
Registration Number
NCT00691860
Lead Sponsor
Corporacion Parc Tauli
Brief Summary

Randomized, controlled, prospective study of 54 patients receiving surgery for cancer of the lower third of the rectum with a permanent end colostomy. The aim of the study was to reduce parastomal hernia (PH) occurrence by implanting a lightweight mesh in the sublay position. Patients were followed up a) clinically and b) radiologically by means of abdominal CT. In the clinical follow-up, hernias were observed in four out of 27 patients (14.8%) in the study group and in eleven out of 27 (40.7%) in the control group (p=0.03). The implantation of the mesh reduces the appearance of PH, is well tolerated, and does not increase morbidity

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
54
Inclusion Criteria
  • patients scheduled for permanent end colostomy to treat cancer of the lower third of the rectum,
  • Aged over 18,
  • Charlson comorbidity index below 7
  • Elective surgery
  • Radical surgery
Exclusion Criteria
  • Loop colostomies,
  • Emergency surgery,
  • Body mass index above 35 kg/sq.m.,
  • Palliative surgery,
  • Hepatic cirrhosis,
  • Severe COPD (requiring home oxygen treatment),
  • Corticoid treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1Conventional sigmoid end colostomyPatients receiving conventional sigmoid end colostomy plus a lightweight mesh Ultrapro®
2Conventional sigmoid end colostomyPatients receiving conventional sigmoid end colostomy, without mesh
1Mesh (Ultrapro ®)Patients receiving conventional sigmoid end colostomy plus a lightweight mesh Ultrapro®
Primary Outcome Measures
NameTimeMethod
the reduction in the incidence of Parastomal Hernia after the mesh placement6 months
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath